AAA
IDIX

Alpine Associates Advisors’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Alpine Associates Advisors’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-618,900
Closed -$14.9M – 109
2014
Q2 		$14.9M Buy
+618,900
New +$6.45M 0.69% 39

Alpine Associates Advisors's IDIX Position: Q3 2014 in Review

Alpine Associates Advisors sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 618,900 shares — an estimated $14.9M sold.

Alpine Associates Advisors first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $14.9M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Alpine Associates Advisors reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Alpine Associates Advisors sold 618,900 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $14.9M.
  • Alpine Associates Advisors first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
  • Alpine Associates Advisors's IDENIX PHARMACEUTICALS INC position peaked at $14.9M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Alpine Associates Advisors's 13F filing for Q3 2014, filed 12 Nov 2014.